These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1484918)

  • 1. The effect of haloperidol on aldosterone secretion.
    Warner MD; Gillespie H; Pavlou SN; Nader S; Peabody CA
    Psychoneuroendocrinology; 1992 Oct; 17(5):517-21. PubMed ID: 1484918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin responses to neuroleptics in normal and schizophrenic subjects.
    Gruen PH; Sachar EJ; Langer G; Altman N; Leifer M; Frantz A; Halpern FS
    Arch Gen Psychiatry; 1978 Jan; 35(1):108-16. PubMed ID: 23087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin bioassay in schizophrenia before and after neuroleptics.
    Peabody CA; Warner MD; Griffin M; Boutros NN; Worsley IG; Friesen HG
    Psychiatry Res; 1992 Mar; 41(3):249-55. PubMed ID: 1594711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haloperidol. Plasma levels and prolactin response as predictors of clinical improvement in schizophrenia: chemical v radioreceptor plasma level assays.
    Smith RC; Baumgartner R; Misra CH; Mauldin M; Shvartsburd A; Ho BT; DeJohn C
    Arch Gen Psychiatry; 1984 Nov; 41(11):1044-9. PubMed ID: 6497566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical state, plasma levels of haloperidol and prolactin: a correlation study in chronic schizophrenia.
    Rao VA; Bishop M; Coppen A
    Br J Psychiatry; 1980 Dec; 137():518-21. PubMed ID: 7214106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal and haloperidol-stimulated prolactin in neuroleptic-free men with schizophrenia defined by 11 diagnostic systems.
    Keks NA; Copolov DL; Kulkarni J; Mackie B; Singh BS; McGorry P; Rubin RT; Hassett A; McLaughlin M; van Riel R
    Biol Psychiatry; 1990 Jun; 27(11):1203-15. PubMed ID: 2354227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum prolactin as a correlate of clinical response to haloperidol.
    Van Putten T; Marder SR; Mintz J
    J Clin Psychopharmacol; 1991 Dec; 11(6):357-61. PubMed ID: 1770154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidiagnostic evaluation of prolactin response to haloperidol challenge in schizophrenia: maximal blunting in Kraepelinian patients.
    Keks NA; McKenzie DP; Low LH; McGorry PD; Hill C; Kulkarni J; Singh BS; Copolov DL
    Biol Psychiatry; 1992 Sep; 32(5):426-37. PubMed ID: 1486148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of prolactin concentrations between haloperidol and bromperidol treatments in schizophrenic patients.
    Yasui-Furukori N; Kondo T; Suzuki A; Mihara K; Kaneko S; Otani K
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):575-8. PubMed ID: 11999910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of prolactin concentrations between haloperidol and risperidone treatments in the same female patients with schizophrenia.
    Yasui-Furukori N; Kondo T; Suzuki A; Mihara K; Kaneko S
    Psychopharmacology (Berl); 2002 Jun; 162(1):63-6. PubMed ID: 12107619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the CYP2D6 genotype on prolactin concentration in schizophrenic patients treated with haloperidol.
    Yasui-Furukori N; Kondo T; Suzuki A; Mihara K; Tokinaga N; Inoue Y; Otani K; Kaneko S
    Schizophr Res; 2001 Oct; 52(1-2):139-42. PubMed ID: 11595402
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective dopamine D2 antagonist and prolactin response in acute schizophrenia--results from remoxipride studies. The Canadian Remoxipride Study Group.
    Awad AG; Lapierre YD; Jostell KG
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(5):769-77. PubMed ID: 2149882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of chlorpromazine on plasma renin activity and aldosterone in man.
    Robertson D; Michelakis AM
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1166-8. PubMed ID: 1206100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indirect evidence to suggest that prolactin mediates the adrenal action of haloperidol to stimulate aldosterone and corticosterone secretion in rats.
    Goebel S; Dietrich M; Jarry H; Wuttke W
    Endocrinology; 1992 Feb; 130(2):914-9. PubMed ID: 1310283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aripiprazole and haloperidol: beneficial combination antipsychotic therapy for a schizophrenic patient.
    Kuo J; Hwu HG
    Clin Neuropharmacol; 2008; 31(3):173-5. PubMed ID: 18520984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haloperidol does not affect the level of serum-soluble interleukin-2 receptor in drug-free male schizophrenics.
    Kim CE; Kang DY; Ha KS; Jeong SH; Kim YS
    Biol Psychiatry; 1995 Dec; 38(12):843-5. PubMed ID: 8750045
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelet aggregation and dense granule secretion in schizophrenia.
    Yao JK; van Kammen DP; Gurklis J; Peters JL
    Psychiatry Res; 1994 Oct; 54(1):13-24. PubMed ID: 7701025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haloperidol and clozapine treatment and their effect on M-chlorophenylpiperazine-mediated responses in schizophrenia: implications for the mechanism of action of clozapine.
    Kahn RS; Siever L; Davidson M; Greenwald C; Moore C
    Psychopharmacology (Berl); 1993; 112(1 Suppl):S90-4. PubMed ID: 7831445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A double-blind study of metoclopramide in the treatment of schizophrenia and determination of prolactin].
    Gu SF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Dec; 25(6):328-30, 382. PubMed ID: 1304992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum level monitoring and therapeutic effect of haloperidol in schizophrenic patients.
    Moulin MA; Davy JP; Debruyne D; Andersson JC; Bigot MC; Camsonne R; Poilpré E
    Psychopharmacology (Berl); 1982; 76(4):346-50. PubMed ID: 6812109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.